sur VALBIOTIS (EPA:ALVAL)
Half-yearly review of the Valbiotis liquidity contract
La Rochelle, July 11, 2024 – Valbiotis, a French laboratory specializing in food supplements for the prevention of metabolic disorders, publishes the half-yearly report of its liquidity contract managed by Portzamparc.
As of June 30, 2024, the liquidity account included 31,296 Valbiotis securities and 25,655.71 euros. In comparison, as of December 31, 2023, it contained 15,349 titles and 59,666.53 euros.
Since the implementation of the contract in 2018, the initial means were 34,500 titles and 10,529.68 euros. For the first half of 2024, 67,938 securities were purchased for 224,228.99 euros in total, and 51,991 securities were sold for 190,218.17 euros.
These figures show a clear increase in the number of securities and active portfolio management during this period.
R. H.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de VALBIOTIS